Page last updated: 2024-08-24

plerixafor and Kidney Failure

plerixafor has been researched along with Kidney Failure in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badel, K; Calandra, G; Hard, ML; MacFarland, R; Scarborough, R	1
Armistead, PM; Gregory, KM; Rao, KV	1
Bokhari, SW; Cook, G; D'Addio, A; Douglas, KW; Hayden, PJ; Lemoli, RM; Maris, M; Masszi, T; Mikala, G; Noppeney, R; Pagliuca, A; Parker, AN; Rahemtulla, A; Rao, K; Scheid, C; Taylor, R; Treisman, J; Uberti, J; Worel, N	1

Trials

1 trial(s) available for plerixafor and Kidney Failure

Article	Year
A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:1 Topics: Adult; Aged; Benzylamines; Cohort Studies; Creatinine; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Receptors, CXCR4; Renal Insufficiency	2010

Article

Year

A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:1

Topics: Adult; Aged; Benzylamines; Cohort Studies; Creatinine; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Receptors, CXCR4; Renal Insufficiency

2010

Other Studies

2 other study(ies) available for plerixafor and Kidney Failure

Article	Year
Plerixafor dosing and administration in a patient with dialysis-dependent renal failure. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:12 Topics: Adult; Benzylamines; Combined Modality Therapy; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Multiple Myeloma; Receptors, CXCR4; Renal Dialysis; Renal Insufficiency	2010
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA. Bone marrow transplantation, 2012, Volume: 47, Issue:1 Topics: Adult; Aged; Anti-HIV Agents; Benzylamines; Blood Component Removal; Cyclams; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kidney Transplantation; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Renal Dialysis; Renal Insufficiency; Transplantation, Autologous; Transplantation, Homologous	2012

Article

Year

Plerixafor dosing and administration in a patient with dialysis-dependent renal failure.

The Annals of pharmacotherapy, 2010, Volume: 44, Issue:12

Topics: Adult; Benzylamines; Combined Modality Therapy; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Multiple Myeloma; Receptors, CXCR4; Renal Dialysis; Renal Insufficiency

2010

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.

Bone marrow transplantation, 2012, Volume: 47, Issue:1

Topics: Adult; Aged; Anti-HIV Agents; Benzylamines; Blood Component Removal; Cyclams; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kidney Transplantation; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Renal Dialysis; Renal Insufficiency; Transplantation, Autologous; Transplantation, Homologous

2012